Barigen 4 mg tablets consist of baricitinib, which is a JAK inhibitor, interfering with particular immune signaling. The administration is based on the condition of the individual, personal medical history, and local prescribing practices. Baricitinib might be indicated in some inflammatory diseases and other approved conditions. Barigen 4 mg tablets are administered if it is appropriate for the condition.
As baricitinib can lead to the development of severe infections, the physician can conduct examinations before and throughout the therapy. The examination includes a blood count and determination of liver enzymes and lipids. Patients need to comply with all recommendations of their healthcare provider.